Adjuvant trastuzumab for breast cancer: uncertainties in clinical and economic evidence following early stopping of the HERA trial
- PMID: 21504237
- DOI: 10.2165/11588350-000000000-00000
Adjuvant trastuzumab for breast cancer: uncertainties in clinical and economic evidence following early stopping of the HERA trial
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
